BAX and hepatocellular carcinoma: Simultaneously, 125I seed at both 0.4 and 0.8mCi doses promoted the mRNA expression of Bax, evidenced by RT-qPCR analysis, while inhibiting that of Bcl-2 in HCC-9810 cells (p < 0.001, Fig. 2G).